Home/Filings/4/0000950170-24-114180
4//SEC Filing

Siegel Jonathan B. 4

Accession 0000950170-24-114180

CIK 0001585608other

Filed

Oct 9, 8:00 PM ET

Accepted

Oct 10, 9:52 PM ET

Size

5.7 KB

Accession

0000950170-24-114180

Insider Transaction Report

Form 4
Period: 2024-10-08
Transactions
  • Award

    Stock option (right to buy)

    2024-10-08+26,50026,500 total
    Exercise: $1.29Exp: 2034-10-08Common Stock (26,500 underlying)
Footnotes (3)
  • [F1]Granted pursuant to the issuer's 2014 Stock Incentive Plan.
  • [F2]The option grant was approved by the issuer's board of directors on October 8, 2024.
  • [F3]The options will vest 100% on the first anniversary of the grant date, so long as the reporting person continues to serve on the board of directors of the issuer and Napo Therapeutics, S.p.A., the issuer's subsidiary, as applicable.

Documents

1 file

Issuer

Jaguar Health, Inc.

CIK 0001585608

Entity typeother

Related Parties

1
  • filerCIK 0001588209

Filing Metadata

Form type
4
Filed
Oct 9, 8:00 PM ET
Accepted
Oct 10, 9:52 PM ET
Size
5.7 KB